Physician reported adherence to immunosuppressants in renal transplant patients: Prevalence, agreement, and correlates

Journal of Psychosomatic Research

Volumn 79, Issue 5, 2015, Pages 364-371

  Pabst, Selma ^a   Bertram, Anna ^a   Zimmermann, Tanja ^a   Schiffer, Mario ^a   de Zwaan, Martina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Immunosuppression; Kidney transplantation; Medication adherence

Indexed keywords

CYCLOSPORIN A; EVEROLIMUS; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PHYSICIAN; PREVALENCE; PSYCHOLOGIC ASSESSMENT; SOCIAL SUPPORT; TREATMENT REFUSAL; ADOLESCENT; AGED; ANXIETY; BLOOD; COMPLICATION; GERMANY; GRAFT REJECTION; KIDNEY TRANSPLANTATION; LANGUAGE; MENTAL DISORDERS; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; GERMANY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LANGUAGE; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; PHYSICIANS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; SOCIAL SUPPORT; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84952062709     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2015.09.001     Document Type: Article

References (52)

1. Dobbels F., Berben L., De Geest S., Drent G., Lennerling A., Whittaker C., Kugler C. Transplant 360 task force. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation 2010, 90(2):205-219. 10.1097/TP.0b013e3181e346cd.
2. Prihodova L., Nagyova I., Rosenberger J., Majernikova M., Roland R., Groothoff J.W., et al. Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study. J. Adv. Nurs. 2014, 70(12):2871-2883. 10.1111/jan.12447.
3. Vlaminck H., Maes B., Evers G., Verbeke G., Lerut E., Van Damme B., et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am. J. Transplant. 2004, 4(9):1509-1513. 10.1111/j.1600-6143.2004.00537.x.
4. Morrissey P.E., Reinert S., Yango A., Gautam A., Monaco A., Gohh R. Factors contributing to acute rejection in renal transplantation: the role of noncompliance. Transplant. Proc. 2005, 37(5):2044-2047. 10.1016/j.transproceed.2005.03.017.
5. Massey E.K., Tielen M., Laging M., Beck D.K., Khemai R., van Gelder T., et al. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. J. Psychosom. Res. 2013, 75(3):229-234. 10.1016/j.jpsychores.2013.07.006.
6. Massey E.K., Tielen M., Laging M., Timman R., Beck D.K., Khemai R., et al. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation. Transplantation 2015, 99(2):375-380. 10.1097/TP.0000000000000608.
7. Dew M.A., DiMartini A.F., De Vito D.A., Myaskovsky L., Steel J., Unruh M., et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007, 83(7):858-873.
8. Tielen M., van Exel J., Laging M., Beck D.K., Khemai R., van Gelder T., et al. Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study. J. Transplant. 2014, 2014:675301. 10.1155/2014/675301.
9. Sellarés J., De Freitas D.G., Mengel M., Reeve J., Einecke G., Sis B., et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am. J. Transplant. 2012, 12(2):388-399. 10.1111/j.1600-6143.2011.03840.x.
10. Schäfer-Keller P., Steiger J., Bock A., Denhaerynck K., De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am. J. Transplant. 2008, 8:616-626. 10.1111/j.1600-6143.2007.02127.x.
11. Denhaerynck K., Burkhalter F., Schäfer-Keller P., Steiger J., Bock A., De Geest S. Clinical consequences of non-adherence to immunosuppressive medication in kidney transplant patients. Transpl. Int. 2009, 22(4):441-446. 10.1111/j.1432-2277.2008.00820.x.
12. Cleemput I., Kesteloot K., Vanrenterghem Y., De Geest S. The economic implications of non-adherence after renal transplantation. PharmacoEconomics 2004, 22(18):1217-1234. 10.2165/00019053-200422180-00006.
13. Osterberg L., Blaschke T. Adherence to medication. N. Engl. J. Med. 2005, 353(5):487-497. 10.1056/NEJMra050100.
14. Shemesh E., Shneider B.L., Savitzky J.K., Arnott L., Gondolesi G.E., Krieger N.R., et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004, 113(4 I):825-832. 10.1542/peds.113.4.825.
15. Zeller A., Taegtmeyer A., Martina B., Battegay E., Tschudi P. Physicians' ability to predict patients' adherence to antihypertensive medication in primary care. Hypertens. Res. 2008, 31(9):1765-1771. 10.1291/hypres.31.1765.
16. Curtis J.R., Cai Q., Wade S.W., Stolshek B.S., Adams J.L., Balasubramanian A., et al. Osteoporosis medication adherence: physician perceptions vs. patients' utilization. Bone 2013, 55(1):1-6. 10.1016/j.bone.2013.03.003.
17. Phillips L.A., Leventhal E.A., Leventhal H. Factors associated with the accuracy of physicians' predictions of patient adherence. Patient Educ. Couns. 2011, 85(3):461-467. 10.1016/j.pec.2011.03.012.
18. Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS 2002;16(13):1835-1837. doi:10.1097/00002030-200209060-00021.
19. Murri R., Antinori A., Ammassari A., Nappa S., Orofino G., Abrescia N., et al. Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2002, 31(Suppl. 3):S158-S162.
20. De Bleser L., Dobbels F., Berben L., Vanhaecke J., Verleden G., Nevens F., et al. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl. Int. 2011, 24(9):882-891. 10.1111/j.1432-2277.2011.01296.x.
21. Schmid-Mohler G., Thut M.P., Wüthrich R.P., Denhaerynck K., De Geest S. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clin. Transpl. 2010, 24(2):213-222. 10.1111/j.1399-0012.2009.01056.x.
22. Butler J.A., Peveler R.C., Roderick P., Horne R., Mason J.C. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004, 77(5):786-789. 10.1097/01.TP.0000110412.20050.36.
23. Dharancy S., Giral M., Tetaz R., Fatras M., Dubel L., Pageaux G. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin. Transpl. 2012, 26(3):E293-E299. 10.1111/j.1399-0012.2012.01652.x.
24. Klaghofer R., Sarac N., Schwegler K., Schleuniger M., Noll G., Muellhaupt B., et al. Questionnaire on emotional response after organ transplantation: German validation of the Transplant Effect Questionnaire (TxEQ-D). Z. Psychosom. Med. Psychother. 2008, 54:174-188.
25. Hsiau M., Fernandez H.E., Gjertson D., Ettenger R.B., Tsai E.W. Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. Transplantation 2011, 92(8):918-922. 10.1097/TP.0b013e31822dc34f.
26. Waiser J., Slowinski T., Brinker-Paschke A., Budde K., Schreiber M., Böhler T., et al. Impact of the variability of cyclosporin a trough levels on long-term renal allograft function. Nephrol. Dial. Transplant. 2002, 17(7):1310-1317.
27. Kahan B.D., Welsh M., Urbauer D.L., Mosheim M.B., Beusterien K.M., Wood M.R., et al. Low intraindividual variability of cyclosporin a exposure reduces chronic rejection incidence and health care costs. J. Am. Soc. Nephrol. 2000, 11(6):1122-1131.
28. Herrmann-Lingen C., Buss U., Snaith R.P. Hospital Anxiety and Depression Scale - Deutsche Version (HADS-D) 1995, Bern, Verlag Hans Huber.
29. Kliem S., Mößle T., Rehbein F., Hellmann D.F., Zenger M., Brähler E. A brief form of the perceived social support questionnaire (F-SozU) was developed, validated, and standardized. J. Clin. Epidemiol. 2015, 68(5):551-562. 10.1016/j.jclinepi.2014.11.003.
30. Vogel I., Miksch A., Goetz K., Ose D., Szecsenyi J., Freund T. The impact of perceived social support and sense of coherence on health-related quality of life in multimorbid primary care patients. Chronic Illn. 2012, 8(4):296-307. 10.1177/1742395312445935.
31. Fritz C.O., Morris P.E., Richler J.J. Effect size estimates: current use, calculations, and interpretation. J. Exp. Psychol. Gen. 2012, 141(1):2-18. 10.1037/a0024338.
32. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Earlbaum Associates, Hillsdale, NJ. 2nd ed.
33. Landis J.R., Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977, 33(2):363-374.
34. Miller L.G., Liu H., Hays R.D., Golin C.E., Beck C.K., Asch S.M., et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy?. J. Gen. Intern. Med. 2002, 17(1):1-11. 10.1046/j.1525-1497.2002.09004.x.
35. Loayza N., Crettol S., Riquier F., Eap C.B. Adherence to antidepressant treatment: what the doctor thinks and what the patient says. Pharmacopsychiatry 2012, 45(5):204-207. 10.1055/s-0032-1306311.
36. Byerly M., Fisher R., Whatley K., Holland R., Varghese F., Carmody T., et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005, 133(2-3):129-133. 10.1016/j.psychres.2004.11.002.
37. Copher R., Buzinec P., Zarotsky V., Kazis L., Iqbal S.U., MacArios D. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims. Curr. Med. Res. Opin. 2010, 26(4):777-785. 10.1185/03007990903579171.
38. Kekäle M., Talvensaari K., Koskenvesa P., Porkka K., Airaksinen M. Chronic myeloid leukemia patients' adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians. Patient Prefer. Adherence 2014, 8:1619-1627. 10.2147/PPA.S70712.
39. Lutfey K.E., Ketcham J.D. Patient and provider assessments of adherence and the sources of disparities: evidence from diabetes care. Health Serv. Res. 2005, 40(6 I):1803-1817. 10.1111/j.1475-6773.2005.00433.x.
40. Tsapepas D., Langone A., Chan L., Wiland A., McCague K., Chisholm-Burns M. A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational REnal Transplant (MORE) study. Ann. Transplant. 2014, 19(1):174-181. 10.12659/AOT.890216.
41. Huizinga M.M., Bleich S.N., Beach M.C., Clark J.M., Cooper L.A. Disparity in physician perception of patients' adherence to medications by obesity status. Obesity 2010, 18(10):1932-1937. 10.1038/oby.2010.35.
42. Teal C.R., Gill A.C., Green A.R., Crandall S. Helping medical learners recognise and manage unconscious bias toward certain patient groups. Med. Educ. 2012, 46(1):80-88. 10.1111/j.1365-2923.2011.04101.x.
43. Alspach J.G. Is there gender bias in critical care?. Crit. Care Nurse 2012, 32(6):8-14. 10.4037/ccn2012727.
44. Gordon E.J., Ladner D.P. Gender inequities pervade organ transplantation access. Transplantation 2012, 94(5):447-448.
45. Couchoud C., Bayat S., Villar E., Jacquelinet C., Ecochard R. REIN registry. A new approach for measuring gender disparity in access to renal transplantation waiting lists. Transplantation 2012, 94(5):513-519.
46. Jindal R.M., Ryan J.J., Sajjad I., Murthy M.H., Baines L.S. Kidney transplantation and gender disparity. Am. J. Nephrol. 2005, 25(5):474-483.
47. Chilcot J., Spencer B.W.J., Maple H., Mamode N. Depression and kidney transplantation. Transplantation 2014, 97(7):717-721. 10.1097/01.TP.0000438212.72960.ae.
48. Gorevski E., Succop P., Sachdeva J., Cavanaugh T.M., Volek P., Heaton P., et al. Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population?. Patient Prefer. Adherence 2013, 7:301-307. 10.2147/PPA.S34945.
49. Wagner J.H., Justice A.C., Chesney M., Sinclair G., Weissman S., Rodriguez-Barradas M., et al. Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J. Clin. Epidemiol. 2001, 54(12 Suppl 1):S91-S98. 10.1016/S0895-4356(01)00450-4.
50. Grant R.W., Wexler D.J., Ashburner J.M., Hong C.S., Atlas S.J. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians. Arch. Intern. Med. 2012, 172(10):821-823. 10.1001/archinternmed.2012.1229.
51. Welch L.C., Litman H.J., Borba C.P., Vincenzi B., Henderson D.C. Does a physician's attitude toward a patient with mental illness affect clinical management of diabetes? Results from a mixed-method study. Health Serv. Res. 2015, 50(4):998-1020. 10.1111/1475-6773.12267.
52. Hahn S.R. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology 2009, 116(11 Suppl.):S37-S42. 10.1016/j.ophtha.2009.06.023.